Andrew Klips became enraptured with the markets as a teenager and has been an active trader on a daily basis for more than a decade. Specializing in technical analysis, he is an avid player of stock charts making technical bottoms mixed with a particular affinity for the fundamentals of biotechnology companies.
Latest Articles
Economic
Hodgepodge of Housing Data an Anchor on Builders in July
SiriusXM Hits Record Number of Subscribers in Q2, Profits Slip
Health
More Tax Inversions: Abbott Selling Part of Generic Drug Business to Mylan for $5.3 Billion
Economic
West Coast Dockworkers Strike Will Cost Economy Billions Every Day
Economic
Initial Jobless Claims Inch Down by 2,000 in Week Ended June 21
Experian Study: Talking About Finances Makes You More Attractive
New Home Sales Join Existing Homes Sales in Beating Forecasts for May
Darden Restaurant Profits Dive 35 Percent in Fiscal Q4
Economic
Initial Jobless Claims Slide Back to 312,000 in Week Ended June 14
Study: 25 Percent of All Merger and Acquisition Deals Involve Insider Trading
Finish Line Q1 Profits Slip on New Macy’s Business Costs, Still Top Expectations
AutoNation Sales Climb 13 Percent in Q2
Economic
Tuesday and Thursday Highlight Economic Data for Week of April 15
Bayer to Spend $1.1 Billion to Broaden Contraception Business
Economic
Initial Jobless Claims Plunge 31,000 to 2006 Lows (Sort of)
